ijcr@oajrc.org

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2022; 6: (10) ; 10.12208/j.ijcr.20220507 .

Wang Bi Tablet in the treatment of osteoarthritis of the knee
尪痹片治疗膝骨关节炎的临床疗效分析

作者: 王飞*,

常州市新北区三井街道河海社区卫生服务中心 江苏常州

*通讯作者: 王飞,单位:常州市新北区三井街道河海社区卫生服务中心 江苏常州;

引用本文: 王飞, 尪痹片治疗膝骨关节炎的临床疗效分析[J]. 国际临床研究杂志, 2022; 6: (10) : 187-189.
Published: 2022/12/31 19:02:03

摘要

目的 研究尪痹片治疗膝骨关节炎的临床疗效。方法 选择2020年01月-2021年12月期间我院门诊治疗的60例膝骨关节炎患者,根据平均分配法,将患者分为研究组和对照组,各30例。对照组患者应用双氯芬酸钠缓释片进行治疗,研究组在对照组基础上应用尪痹片进行治疗,对比两组临床疗效。结果 研究组总有效率高于对照组;治疗后研究组症候体征积分低于对照组;临床相关指优于对照组,生活质量评分高于对照组,差异明显(P<0.05)。两组患者均未出现明显不良反应。结论 尪痹片治疗膝骨关节的疗效确切,可有效缓解患者的临床症状,调节机体血清炎症因子水平,延缓病情的发展,具有较高的安全性,可帮助患者提高生活质量。

关键词: 尪痹片;双氯芬酸钠缓释片;膝骨关节炎;临床疗效;安全性

Abstract

Objective To study the clinical efficacy of Wang Bi tablet in the treatment of osteoarthritis of the knee.
Methods: a total of 60 patients with osteoarthritis of the knee, who were treated in our hospital from January 2020 to December 2020, were 2021 into study group and control group. The patients in the control group were treated with diclofenac sustained-release tablets, while the patients in the research group were treated with Wang Bi tablets in addition to the control group. The clinical efficacy of the two groups was compared.
Results: the total effective rate of the study group was higher than that of the control group, the scores of symptoms and signs of the study group were lower than those of the control group after treatment, the clinical correlation index was better than that of the control group, the score of quality of life was higher than that of the control group, the difference was significant (p < 0.05) . There were no obvious adverse reactions in both groups.
Conclusion  : Wang Bi Tablet is effective in the treatment of knee joint, it can effectively relieve the clinical symptoms, regulate the level of serum inflammatory factors, delay the development of the disease, and has a high safety, can help patients improve the quality of life.

Key words: Wang Bi tablets; diclofenac sustained-release tablets; knee osteoarthritis; clinical efficacy; safety

参考文献 References

[1] 陈欣,刘建军,董万涛,等.膝骨性关节炎合并骨质疏松症调节机制的研究进展[J].中国骨质疏松杂志,2022, 28(4):607-612,624.

[2] 李辉,李宁,谢兴文,等.中医药干预基质金属蛋白酶表达治疗膝骨性关节炎研究进展[J].中国骨质疏松杂志,2022,28(1):120-123,138.

[3] 王馨苑,黄夏冰,李娟,等.桃红四物汤"异病同治"类风湿性关节炎和骨关节炎的网络药理学及分子对接分析[J].中国组织工程研究,2022,26(15):2419-2425.

[4] 陶江涛,马玉,张敏.尪痹片联合美洛昔康治疗膝骨关节炎临床研究[J].新中医,2021,53(11):85-87.

[5] 陈卫衡,翁习生,阎小萍,等.尪痹片治疗类风湿关节炎/膝骨关节炎临床应用专家共识[J].中国中药杂志,2021, 46(17): 4569-4574.

[6] 邓彦俊,焦长庚,赵斌,等.尪痹片联合双醋瑞因治疗膝骨关节炎的临床研究[J].现代药物与临床,2021,36(7): 1435-1439.

[7] 帅波,沈霖,马陈,等.尪痹片联合甲氨蝶呤片对类风湿性关节炎患者血清DKK-1及关节滑膜侵蚀的影响[J].中国中医骨伤科杂志,2020,28(6):16-20.

[8] 高智艳.自拟痹痛方加减治疗痹证疗效观察[J].实用中西医结合临床,2019,19(6):80-81.

[9] 傅艳芬,罗仕,陈锦荣,等.尪痹胶囊联合甲氨蝶呤治疗类风湿关节炎临床研究[J].中国药业,2019,28(5):55-57.

[10] 寇龙威,郭艳幸,郭珈宜.中医药治疗膝骨关节炎的研究进展[J].中医药通报,2019,18(6):71-73,67.